APOE ε4 Allele Dose and Time to Clinical Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Dementia: An ADNI Survival Analysis
Faizaan Fazal Khan, Goo-Rak Kwon · 2026
Read APOE ε4 Allele Dose and Time to Clinical Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Dementia: An ADNI Survival Analysis by Faizaan Fazal Khan, Goo-Rak Kwon (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13297606.txt.
Description
Faizaan Fazal Khan and Goo-Rak Kwon ask whether carrying more copies of a risk gene variant speeds the slide from mild memory trouble to Alzheimer's dementia, in a 2026 study. The variant, APOE ε4, is often treated as a simple yes-or-no factor. Records from a large imaging initiative covered 1,115 people with mild impairment, grouped by whether they held zero, one, or two copies.
Just over a third worsened to dementia during follow-up. Typical time without worsening fell sharply with each added copy. It ran from over eighteen years with no copy to under three and a half years with two copies. The no-copy figure rests on late follow-up, though. Each copy raised the hazard even after brain size and test scores were counted. Larger memory-centre volume, by contrast, protected.
Catalog record
| CREATOR | Faizaan Fazal Khan, Goo-Rak Kwon |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |